A Two Arm, Multi-Centre Clinical Evaluation of the NxTAG Respiratory Pathogen Panel
NCT01787227
Bronchial Diseases, Bronchiolitis
St Louis, Missouri, United States
View Trial DetailsNCT Number: NCT00265187
Sputum specimens will be obtained from children < 2 years of age and processed by different mode for the HMPV, RSV, Pertussis, Influenza A, B, Parainfluenza 1,2,3, Adenovirus. Clinical and epidemiological data will also be obtained.
Looking for future studies?
Notify Me1 day–2 year
All sexes
Observational
Pediatric department A, HaEmek Medical Center, Afula, Israel
The purpose of the study is to asses the various pathogens of bronchiolitis in children and its' clinical manifestations. Prospective study in 3 Medical centers in Northern Israel. Included will be about 200 infants and children < 2 years hospitalized with bronchiolitis. From each child sputum specimen will be obtained and processed for HUMP - PCR, Pertussis - PCR, RSV - ELISA, DFA, PCR, Influenza A, B, Parainfluenza 1,2,3 - DFA, PCR, Adenovirus - DFA. Epidemiological data will be obtained for every child by structured questioner. Clinical data will be daily obtained by scoring system.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Age 0-24 months, hospitalized children, -
Exclusion criteria
Previous hospitalization, previous RSV immunization, immunocompromised patient, previous inclusion in this study, inclusion in another study.
-
HaEmek Medical Center, Israel
Other
The Prevalence and Clinical Manifestations of Human Metapneumovirus Among Children With Bronchiolitis in Northern Israel.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01787227
Bronchial Diseases, Bronchiolitis
St Louis, Missouri, United States
View Trial DetailsNCT07552779
COVID-19, COVID-19 (Coronavirus Disease 2019)
Brussels, Bruxelles-capitale, Région de, Belgium
View Trial DetailsNCT06482099
Infections, Respiratory Tract Diseases
Tokyo, Japan
View Trial DetailsNCT06974747
Infections, Respiratory Tract Diseases
Prague, Czechia
View Trial Details